US Liquids Inc. Employment Term Sheet for William M. DeArman as Chairman and Interim CEO

Contract Categories: Business Finance Term Sheets
Summary

US Liquids Inc. offers William M. DeArman the role of Chairman and Interim CEO, reporting to the Board of Directors, with a $240,000 base salary and an annual bonus targeted at 50% of salary. He will receive stock options for 300,000 shares vesting over three years, with accelerated vesting under certain conditions. If terminated without cause or for Good Reason, he is entitled to one year of severance pay and continued medical insurance. Standard executive benefits apply, and he may serve on one outside public company board.

EX-10.29 6 h01125exv10w29.htm TERM SHEET FOR EMPLOYMENT - WILLIAM M. DEARMAN exv10w29  

Exhibit 10.29

US LIQUIDS INC.
COMPENSATION PROPOSAL
William M. DeArman

     
Title   Chairman and Interim Chief Executive Officer; direct report to Board of Directors.
     
Base Salary   $240,000
     
Incentive Plan   Annual cash bonus targeted at 50% of base salary. Bonus formula to be determined annually by Company’s compensation committee and consistent with position and formula established for other executive officers.
     
Equity Awards   Option grant at current stock price for 300,000 shares. Vesting monthly over 3 years. Only 100,000 shares vested if employment is terminated prior to one year from date of employment. In the event employee’s position is made permanent then full vesting on sale, change of control, termination without cause, termination by employee for Good Reason (see severance agreement)
     
Employment Agreement   None.
     
Severance
Agreement
  Applicable the earlier of one year after date of employment as Interim CEO or time at which employee’s position is made permanent.
     
    Severance Pay: one year for “Termination Without Cause” or termination by employee for “Good Reason”. Severance amount based on total cash compensation. Continuation of medical insurance during severance period.
     
    Good Reason: Customary, but specifically including relocation, reduction in compensation, reduction in responsibilities, change of control of more than 30% (unless from raising new capital or restructuring), failure to have D&O insurance in force, wrongful acts by executive officers which are not cured (e.g. violations of Sarbanes Oxley, etc.)
     
Benefits   Insurance, retirement plan, and other benefits consistent with those of other executive officers.
     
Other   One outside public company board position is permissible